John G Houston is President and CEO of ARVINAS, INC.. Currently has a direct ownership of 1.04 Million shares of ARVN, which is worth approximately $19.8 Million. The most recent transaction as insider was on Feb 23, 2024, when has been sold 5,196 shares (Common Stock) at a price of $47.05 per share, resulting in proceeds of $244,471. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.04M
0% 3M change
13.0% 12M change
Total Value Held $19.8 Million

John G Houston Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2024
SELL
Open market or private sale
$244,471 $47.05 p/Share
5,196 Reduced 0.5%
1,036,681 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
124,450 Added 10.67%
1,041,877 Common Stock
Mar 01 2023
SELL
Open market or private sale
$173,577 $29.53 p/Share
5,878 Reduced 0.64%
917,427 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
17,510 Added 1.86%
923,305 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
61,975 Added 6.4%
905,795 Common Stock
Mar 04 2022
SELL
Open market or private sale
$385,175 $63.94 p/Share
6,024 Reduced 0.71%
843,820 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
-
17,511 Added 2.02%
849,844 Common Stock
Nov 01 2021
SELL
Open market or private sale
$3,519,600 $87.99 p/Share
40,000 Reduced 4.59%
832,333 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$640,000 $16.0 p/Share
40,000 Added 4.38%
872,333 Common Stock
Sep 02 2021
BUY
Exercise of conversion of derivative security
$75,040 $16.0 p/Share
4,690 Added 0.56%
832,333 Common Stock
Aug 02 2021
SELL
Open market or private sale
$4,538,012 $98.82 p/Share
45,922 Reduced 5.26%
827,643 Common Stock
Aug 02 2021
BUY
Exercise of conversion of derivative security
$734,752 $16.0 p/Share
45,922 Added 4.99%
873,565 Common Stock
Jun 10 2021
SELL
Open market or private sale
$3,580,220 $81.58 p/Share
43,886 Reduced 5.04%
827,643 Common Stock
Jun 10 2021
BUY
Exercise of conversion of derivative security
$702,176 $16.0 p/Share
43,886 Added 4.79%
871,529 Common Stock
Jun 09 2021
SELL
Open market or private sale
$56,105 $80.15 p/Share
700 Reduced 0.08%
827,643 Common Stock
Jun 09 2021
BUY
Exercise of conversion of derivative security
$11,200 $16.0 p/Share
700 Added 0.08%
828,343 Common Stock
Mar 02 2021
SELL
Open market or private sale
$628,507 $77.45 p/Share
8,115 Reduced 0.97%
827,643 Common Stock
Mar 02 2021
BUY
Exercise of conversion of derivative security
-
17,510 Added 2.05%
835,758 Common Stock
Feb 16 2021
SELL
Open market or private sale
$3,478,640 $79.06 p/Share
44,000 Reduced 5.12%
816,200 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$704,000 $16.0 p/Share
44,000 Added 4.87%
860,000 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$24,960 $16.0 p/Share
1,560 Added 0.19%
817,760 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$8,996 $29.02 p/Share
310 Added 0.04%
818,248 Common Stock
Jun 30 2020
BUY
Grant, award, or other acquisition
$8,978 $28.5 p/Share
315 Added 0.04%
817,938 Common Stock

Also insider at

NXTC
NextCure, Inc. Healthcare
JGH

John G Houston

President and CEO
New Haven, CT

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Track Activities on ARVN